Logo image of SYM

SYMBOTIC INC (SYM) Stock Fundamental Analysis

NASDAQ:SYM - Nasdaq - US87151X1019 - Common Stock - Currency: USD

31.16  -1.29 (-3.98%)

After market: 31.397 +0.24 (+0.76%)

Fundamental Rating

4

Taking everything into account, SYM scores 4 out of 10 in our fundamental rating. SYM was compared to 128 industry peers in the Machinery industry. While SYM seems to be doing ok healthwise, there are quite some concerns on its profitability. SYM is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SYM was profitable.
In the past year SYM had a positive cash flow from operations.
SYM had negative earnings in each of the past 5 years.
In multiple years SYM reported negative operating cash flow during the last 5 years.
SYM Yearly Net Income VS EBIT VS OCF VS FCFSYM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

The Return On Assets of SYM (-0.63%) is worse than 69.53% of its industry peers.
With a Return On Equity value of -6.03%, SYM is not doing good in the industry: 71.09% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.63%
ROE -6.03%
ROIC N/A
ROA(3y)-1.41%
ROA(5y)-24.27%
ROE(3y)-9735.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SYM Yearly ROA, ROE, ROICSYM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

1.3 Margins

SYM has a worse Gross Margin (15.71%) than 79.69% of its industry peers.
SYM's Gross Margin has improved in the last couple of years.
SYM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.29%
GM growth 5YN/A
SYM Yearly Profit, Operating, Gross MarginsSYM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

6

2. Health

2.1 Basic Checks

SYM does not have a ROIC to compare to the WACC, probably because it is not profitable.
SYM has more shares outstanding than it did 1 year ago.
SYM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SYM Yearly Shares OutstandingSYM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SYM Yearly Total Debt VS Total AssetsSYM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

SYM has an Altman-Z score of 6.45. This indicates that SYM is financially healthy and has little risk of bankruptcy at the moment.
SYM's Altman-Z score of 6.45 is amongst the best of the industry. SYM outperforms 85.94% of its industry peers.
SYM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.45
ROIC/WACCN/A
WACC10.16%
SYM Yearly LT Debt VS Equity VS FCFSYM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

A Current Ratio of 1.02 indicates that SYM should not have too much problems paying its short term obligations.
With a Current ratio value of 1.02, SYM is not doing good in the industry: 88.28% of the companies in the same industry are doing better.
SYM has a Quick Ratio of 1.02. This is a bad value and indicates that SYM is not financially healthy enough and could expect problems in meeting its short term obligations.
SYM has a worse Quick ratio (0.92) than 66.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.92
SYM Yearly Current Assets VS Current LiabilitesSYM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 107.73% over the past year.
Looking at the last year, SYM shows a very strong growth in Revenue. The Revenue has grown by 35.77%.
Measured over the past years, SYM shows a very strong growth in Revenue. The Revenue has been growing by 77.99% on average per year.
EPS 1Y (TTM)107.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)35.77%
Revenue growth 3Y92.19%
Revenue growth 5Y77.99%
Sales Q2Q%27.66%

3.2 Future

Based on estimates for the next years, SYM will show a very strong growth in Earnings Per Share. The EPS will grow by 120.77% on average per year.
The Revenue is expected to grow by 26.47% on average over the next years. This is a very strong growth
EPS Next Y600.68%
EPS Next 2Y278.97%
EPS Next 3Y170.73%
EPS Next 5Y120.77%
Revenue Next Year25.83%
Revenue Next 2Y28.73%
Revenue Next 3Y25.52%
Revenue Next 5Y26.47%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SYM Yearly Revenue VS EstimatesSYM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
SYM Yearly EPS VS EstimatesSYM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 0.6 0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 1558.00, SYM can be considered very expensive at the moment.
Based on the Price/Earnings ratio, SYM is valued a bit more expensive than the industry average as 75.78% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 26.32, SYM is valued quite expensively.
A Price/Forward Earnings ratio of 64.63 indicates a quite expensive valuation of SYM.
70.31% of the companies in the same industry are cheaper than SYM, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, SYM is valued quite expensively.
Industry RankSector Rank
PE 1558
Fwd PE 64.63
SYM Price Earnings VS Forward Price EarningsSYM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 500 1K 1.5K

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, SYM is valued a bit more expensive than 67.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 51.02
EV/EBITDA N/A
SYM Per share dataSYM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SYM's earnings are expected to grow with 170.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.59
PEG (5Y)N/A
EPS Next 2Y278.97%
EPS Next 3Y170.73%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SYM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SYMBOTIC INC

NASDAQ:SYM (6/17/2025, 8:20:02 PM)

After market: 31.397 +0.24 (+0.76%)

31.16

-1.29 (-3.98%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-28 2025-07-28/bmo
Inst Owners82.39%
Inst Owner Change0.67%
Ins Owners0.46%
Ins Owner Change0.02%
Market Cap18.37B
Analysts73.91
Price Target32.58 (4.56%)
Short Float %17.45%
Short Ratio12.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-118.31%
Min EPS beat(2)-121.96%
Max EPS beat(2)-114.67%
EPS beat(4)1
Avg EPS beat(4)-98.15%
Min EPS beat(4)-157.01%
Max EPS beat(4)1.03%
EPS beat(8)3
Avg EPS beat(8)-41.59%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.42%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)2.7%
Revenue beat(4)3
Avg Revenue beat(4)6.78%
Min Revenue beat(4)-1.85%
Max Revenue beat(4)21.43%
Revenue beat(8)6
Avg Revenue beat(8)9.06%
Revenue beat(12)10
Avg Revenue beat(12)16.55%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.85%
PT rev (3m)-6.41%
EPS NQ rev (1m)-16.15%
EPS NQ rev (3m)-24.83%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.18%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-2.41%
Valuation
Industry RankSector Rank
PE 1558
Fwd PE 64.63
P/S 9.04
P/FCF 51.02
P/OCF 43.17
P/B 89.44
P/tB 1677.52
EV/EBITDA N/A
EPS(TTM)0.02
EY0.06%
EPS(NY)0.48
Fwd EY1.55%
FCF(TTM)0.61
FCFY1.96%
OCF(TTM)0.72
OCFY2.32%
SpS3.45
BVpS0.35
TBVpS0.02
PEG (NY)2.59
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.63%
ROE -6.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.71%
FCFM 17.72%
ROA(3y)-1.41%
ROA(5y)-24.27%
ROE(3y)-9735.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.29%
GM growth 5YN/A
F-Score6
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 176.76%
Cap/Sales 3.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.92
Altman-Z 6.45
F-Score6
WACC10.16%
ROIC/WACCN/A
Cap/Depr(3y)206.19%
Cap/Depr(5y)195.83%
Cap/Sales(3y)2.24%
Cap/Sales(5y)3.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y600.68%
EPS Next 2Y278.97%
EPS Next 3Y170.73%
EPS Next 5Y120.77%
Revenue 1Y (TTM)35.77%
Revenue growth 3Y92.19%
Revenue growth 5Y77.99%
Sales Q2Q%27.66%
Revenue Next Year25.83%
Revenue Next 2Y28.73%
Revenue Next 3Y25.52%
Revenue Next 5Y26.47%
EBIT growth 1Y37.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year251.5%
EBIT Next 3Y95.28%
EBIT Next 5Y83.91%
FCF growth 1Y1357.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y803.62%
OCF growth 3YN/A
OCF growth 5YN/A